Medicenna Therapeutics Analyst Ratings
Medicenna Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Medicenna Therapeutics (MDNA) rating was a reiterated with a price target of $0.00 to $2.50. The current price Medicenna Therapeutics (MDNA) is trading at is $0.75, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/08/2023 | 232.89% | HC Wainwright & Co. | → $2.5 | Reiterates | → Buy |
| 11/08/2022 | 232.89% | HC Wainwright & Co. | $4 → $2.5 | Maintains | Buy |
| 08/16/2022 | 432.62% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
| 06/23/2022 | 1231.56% | Oppenheimer | $12 → $10 | Maintains | Outperform |
| 06/23/2022 | 565.78% | HC Wainwright & Co. | $7 → $5 | Maintains | Buy |
| 06/01/2021 | 832.09% | HC Wainwright & Co. | $8 → $7 | Maintains | Buy |
| 12/18/2020 | 1497.87% | Oppenheimer | → $12 | Initiates Coverage On | → Outperform |
| 12/17/2020 | 1497.87% | Oppenheimer | → $12 | Initiates Coverage On | → Outperform |
| 09/10/2020 | 965.25% | HC Wainwright & Co. | → $8 | Initiates Coverage On | → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 02/08/2023 | 232.89% | HC 溫賴特 & 有限公司. | → 2.5 美元 | 重申 | → 購買 |
| 11/08/2022 | 232.89% | HC 溫賴特 & 有限公司. | 4 美元 → 2.5 美元 | 維護 | 購買 |
| 2022 年 8 月 16 日 | 432.62% | HC 溫賴特 & 有限公司. | 5 美元 → 4 美元 | 維護 | 購買 |
| 06/23/2022 | 1231.56% | 奧本海默 | 十二元 → 十美元 | 維護 | 跑贏大市 |
| 06/23/2022 | 565.78% | HC 溫賴特 & 有限公司. | 7 美元 → 5 美元 | 維護 | 購買 |
| 2021 年 1 月 6 日 | 832.09% | HC 溫賴特 & 有限公司. | 8 美元 → 7 美元 | 維護 | 購買 |
| 12/18/2020 | 1497.87% | 奧本海默 | → 十二美元 | 啟動覆蓋範圍 | → 跑贏大市 |
| 12/17/2020 | 1497.87% | 奧本海默 | → 十二美元 | 啟動覆蓋範圍 | → 跑贏大市 |
| 09/10/2020 | 965.25% | HC 溫賴特 & 有限公司. | → 8 美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for Medicenna Therapeutics (MDNA)?
美第納治療（MDNA）的目標價格是多少？
The latest price target for Medicenna Therapeutics (NASDAQ: MDNA) was reported by HC Wainwright & Co. on February 8, 2023. The analyst firm set a price target for $2.50 expecting MDNA to rise to within 12 months (a possible 232.89% upside). 5 analyst firms have reported ratings in the last year.
韋賴特有限公司於 2023 年 2 月 8 日報導了美第根納斯達克股份有限公司（納斯達克代碼：MDNA）的最新價格目標。該分析師公司設定了 2.50 美元的價格目標，預計 MDNA 將在 12 個月內上升（可能是 232.89％ 的上行情況）。5 家分析師公司在去年報告了評級。
What is the most recent analyst rating for Medicenna Therapeutics (MDNA)?
美第納治療（MDNA）的最新分析師評級為何？
The latest analyst rating for Medicenna Therapeutics (NASDAQ: MDNA) was provided by HC Wainwright & Co., and Medicenna Therapeutics reiterated their buy rating.
Medenna 治療學（納斯達克代碼：MDNA）的最新分析師評級由 HC 溫賴特公司提供，梅迪根納治療學重申了他們的購買評級。
When is the next analyst rating going to be posted or updated for Medicenna Therapeutics (MDNA)?
Medicenna 治療學（MDNA）的下一個分析師評級何時會發布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medicenna Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medicenna Therapeutics was filed on February 8, 2023 so you should expect the next rating to be made available sometime around February 8, 2024.
分析師在進行了廣泛的研究後獲得了股票評級，其中包括通過公共財務報表，與 Medicenna Therapeutics 的高管和客戶交談以及收聽盈利電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。Medicenna 治療學的最後評級於 2023 年 2 月 8 日提交，因此您應該期望下一個評級將在 2024 年 2 月 8 日左右提供。
Is the Analyst Rating Medicenna Therapeutics (MDNA) correct?
分析師評級梅迪森納治療學（MDNA）是否正確？
While ratings are subjective and will change, the latest Medicenna Therapeutics (MDNA) rating was a reiterated with a price target of $0.00 to $2.50. The current price Medicenna Therapeutics (MDNA) is trading at is $0.75, which is within the analyst's predicted range.
儘管評級是主觀的並且會發生變化，但最新的 Medenna 治療（MDNA）評級重申，目標價格為 0.00 美元至 2.50 美元。目前的價格美第納治療（MDNA）的交易價格為 0.75 美元，該價格在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。
